Jonah Comstock
One of the biggest ways the changing digital health landscape will affect the pharma industry is that pharma companies increasingly stand to lose control over their own stories, according to a new report from McKinsey & Company, who spoke to 20 thought leaders in various pharma-adjacent sectors.
What do dating apps have to do with health and fitness? Last month, that would have been a hard question to answer, but two news bites this week suggest there are few different ways two should get together.
The judge in the case of Teladoc versus the Texas Medical Board has denied the board’s motion to dismiss the suit, responding to each of three claims that the suit was invalid, originally made in September.
Hackensack, New Jersey-based Vidyo, a videoconferencing company that works with healthcare stakeholders, has raised a $10 million strategic investment from Kaiser Permanente Ventures and another $5 million from existing investors.
All but eight states introduced at least one bill related to telemedicine to their state legislature in 2015, according to a new report from the National Conference of State Legislatures.
Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, movement disorders, and incontinence.
One of the many tensions in digital health is between innovators with big new ideas about new streams of data and doctors and CIOs who have to figure out how to use that data and integrate it into their workflow.
The CVS MinuteClinic will roll out new mobile app features in 2016, MinuteClinic President Dr.
Mobile therapy startup Talkspace is partnering with two universities to validate its text- and video-based mental health services.
Dr Jay Parkinson, founder and Chief Medical Officer of Sherpaa, has long been an outspoken critic of video visits as the increasingly de facto modality for telemedicine.